Clinical experience treating Paecilomyces lilacinus keratitis in four patients | Zendy

Yu Monden | Zendy; Minoru Sugita | Zendy; Ryoji Yamakawa | Zendy; Kazuko Nishimura | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical experience treating Paecilomyces lilacinus keratitis in four patients

Author(s) -

Yu Monden,

Minoru Sugita,

Ryoji Yamakawa,

Kazuko Nishimura

Publication year - 2012

Publication title -

clinical ophthalmology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.025

H-Index - 56

eISSN - 1177-5483

pISSN - 1177-5467

DOI - 10.2147/opth.s29379

Subject(s) - medicine , keratitis , ophthalmology , paecilomyces , dermatology , optometry , botany , biology

Paecilomyces lilacinus is a saprobic fungus that occasionally causes keratitis in infected patients. Voriconazole, a triazole antifungal agent, is often administered to treat P. lilacinus keratitis, because it is resistant to many antifungal agents. However, some patients may not require voriconazole. Here, we report our experience of treating this infection and compare outcomes between patients treated with or without voriconazole.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research